Wonderful to have amazing ⁦⁦⁦@cityofhope⁩ colleagues/partners who gave inspiring talks this evening about the state of the science in #gynecologiconcology #summit ⁦@cityofhopeoc⁩ ⁦@DrSCohen⁩ ⁦@TDellingerMD⁩ #teamscience

Wonderful two days working with fellows from across the country. Cures for cancer require great surgery. I'm confident meeting these wonderful young surgeons that patients will be in great hands. #SGOFellowsCourse. @SGO_org @TDellingerMD @SGO_org

City of Hope PIPAC trials in gastric and biliary tract cancer featured at @PSOGI_EC PSOGI 2025 in Barcelona @MustafaRaoofMD #yanghee Woo @cityofhope @CityofHopeSurg by @WimCeelen nanoparticle IP trial talk

Excited be at ASCO to present our collaboration with CHU Lyon on potential predictive biomarkers for response to HIPEC @cityofhope @COH_GynOncology @CityofHopeSurg @ISSPP1 @PSOGI_EC @bakrinna

Excited to visit Albert Einstein for the PIPAC master course this week @ISSPP1 #US PIPAC Collaborative @RafaelSeitenfus @pipacbrasil @MAReymond @COH_GynOncology @CityofHopeSurg

It's a pleasure to share our newly published Video-article on Classic and Visceral-sparing Pelvic peritonectomy for Peritoneal Surface Malignancies in Annals of Surgical Oncology-hope you enjoy it! rdcu.be/dWCIP @AnnSurgOncol @PSOGI_EC @indepso @ESSOnews @SocSurgOnc

Gyn onc surgeons cooking Mediterranean cuisine - surgeons translating OR skills into delicious meals @COH_GynOncology @CityofHopeSurg @cityofhopeoc @ErnestHanMD

PIPAC-Ox vs. 3rd-line standard therapy for CRC & AC carcinomatosis in @AnnSurgOncol Promising future for PIPAC ⬆️ Good days- days alive & outside 🏥 ⬆️ OS- 11.3 vs. 5.1 mo ⬆️ PFS- 2.9 vs. 2.1 mo: NS Next step ❓Randomized Trial ! @MustafaRaoofMD @TDellingerMD @COH_SurgOnc

PIPAC mitomycin C study is feasible and shows promising response, by @MustafaRaoofMD on behalf of U.S. PIPAC Consortium at @PSOGI_EC @ISSPP1 meeting in Lyon @merchea_md #larrywhelan @DKDePeralta @CityofHopeSurg @COH_GynOncology

Walk for hope at @CityofHopeSurg @COH_GynOncology @ErnestHanMD

Amazing progress for #PIPAC in 🇺🇸. From treating the 1st patient @MayoClinic, to launching the 1st clinical trial led by @MustafaRaoofMD @TDellingerMD @cityofhope & with @DKDePeralta @NorthwellHealth. Now training the next group of 🇺🇸 surgeons at 2nd US PIPAC Workshop. #teamwork

Happy to announce our second PIPAC training course taking place in July 28 and 29, 2024 at City of Hope, CA. cme.cityofhope.org/content/s… @MustafaRaoofMD @ISSPP1 @merchea_md @COH_GynOncology @CityofHopeSurg

Brilliant study to de-escalate platinum sensitive recurrent ovarian cancer therapy after 2’ CRS w/ olaparib pre postop vs adjuv. chemo alone (Lheureux, ASCO). Would love to see a study adding HIPEC here given synergy with PARPi @StephanieLheur5 @ClasseJean @wvdriel

#AudioVisualAbstract : Impact of #SodiumThiosulfate on Prevention of Nephrotoxicities in #HIPEC : An Ancillary Evaluation of Cisplatin-Induced Toxicities in #OvarianCancer @RSenMD @TDellingerMD rdcu.be/dHx1a @SyedAAhmad5 @esragbilir

Investigating PIPAC in the US has been a huge team effort @merchea_md #larrywhelan @TDellingerMD @mgfakih @Yanghee61217641 @DKDePeralta. Thanks @SocSurgOnc @RupenShahMD @SamRuff_MD for inviting us! Bottom line: we need well designed randomized trials to move the needle in PSM

@IspsmHipec @somusp9 @ECPSOGI @TDellingerMD @ISSPP1 @oliviawriting @DeliaCortesGuir @DrSGlezMoreno @RobellaManuela

📅Save the Date! 📢 The first PSOGI-ISSPP joint congress on peritoneal surface malignancies ⌛ 26-28 september 2024 / Lyon, France 🤝 The principal key word of this event will be “Multidisciplinary” around the peritoneum. Follow '14th international congress PSOGI/ISSPP' on linked-in for regular updates linkedin.com/posts/14th-inte… ❗ More information on the official website: lnkd.in/eyJs7H5Y ➕ Join our mailing list to receive all the news from the congress: lnkd.in/e32qpexS This is the first congress that will join forces from the Peritoneal Surface Oncology Group International (PSOGI) and the ISSPP e.V. | International Society for the Study of Pleura and Peritoneum, the two major International Organizations dedicated to the management of Peritoneal Surface Malignancies (PSM). @RENAPE_Network @glehenolivier @PSugarbaker @bakrinna @VahanKepenekian @FredericBibeau #MARCPOCARD @speritoneum @ISSPP1 @APeritoneum @indepso @Israelisso @Some4SurgeryIT1 @IJGConline @alarjosan @AndreasBrandl8 @Elizabeth_Tremb @ANikiforchin @kturaga @AmanielKefley @KurtSpeeten @ESSOnews @ejsotweets @SocSurgOnc @AnnSurgOncol @NirajGusani @CarlosHFChan @Dr_Jamie_Murphy @FaekJ @MustafaRaoofMD @TDellingerMD @dr_mohammadyami @mssalshahrani @docswapnil01 @NewsJellybelly @PMPSurvivor

Still time to register for the @ESSOnews webinar on surgical technique of CRS-Part 1! Tomorrow 28 Nov we will review surgical videos and reveal all the tips&tricks of pelvic peritonectomy. Happy to share the discussion with @DrSGlezMoreno @VadimGushchin6 @TDellingerMD

Unique opportunity to learn from the very best! Technical aspects of pelvic peritonectomy.. Do not miss this free @ESSOnews webinar with @LanaBijelicMD @DrSGlezMoreno @VadimGushchin6 @TDellingerMD @IJGConline @IJGCfellows @agz_eriksson @Bhandoria @JayrajAarthi @OncoAlert @EYSAC1

This is an invitation to the webinar about; CRS for PSM: pelvic peritonectomy with and without visceral resection. Speaker: @LanaBijelicMD, Moderators: @TDellingerMD, @DrSGlezMoreno, and @VadimGushchin6 . Date: 28 November 2023 essoweb.org/courses/esso-web…